Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function in Patients With Cirrhosis and Recurrent or Refractory Ascites

NCT01438970 is registered in ClinicalTrials.gov with Sequana Medical N.V. as lead sponsor.

NCT NCT01438970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01438970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function in Patients With Cirrhosis and Recurrent or Refractory Ascites
Lead sponsor
Sequana Medical N.V.
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2011
Completion date
December 31, 2016
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, refractory ascites